Monday, November 6, 2017
- 9:00AM-11:00AM
-
Abstract Number: 1084
Emdhaq: (electronic multidimensional health assessment questionnaire) to Record and Document eRAPID3 (electronic routine assessment of patient index data3) and eFAST3 (electronic fibromyalgia assessment screening tool3) in Routine Rheumatology Care
Measures and Measurement of Healthcare Quality Poster I- 9:00AM-11:00AM
-
Abstract Number: 1608
Entheseal Involvement in Systemic Lupus Erythematosus: An Ultrasound Study
Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster II: Damage and Comorbidities- 9:00AM-11:00AM
-
Abstract Number: 1168
Eosinophilic Fasciitis: Baseline Retrospective Evaluation of Clinical Characteristics and Prognosis in a Cohort of 83 Patients
Miscellaneous Rheumatic and Inflammatory Diseases Poster I- 9:00AM-11:00AM
-
Abstract Number: 982
Epidemiology and Mortality in Systemic Sclerosis in South Korea: A Nationwide Population-Based Study
Epidemiology and Public Health Poster II: Rheumatic Diseases Other than Rheumatoid Arthritis- 9:00AM-11:00AM
-
Abstract Number: 1379
Epithelial Neutrophil-Activating Peptide 78/C-X-C Motif Chemokine 5 in the Insulin Resistance of Patients with Rheumatoid Arthritis
Rheumatoid Arthritis – Clinical Aspects Poster II: Pathophysiology, Autoantibodies, and Disease Activity Measures- 9:00AM-11:00AM
-
Abstract Number: 1233
Establishing and Maintaining a Volunteer Charity Rheumatology Clinic: One Clinic’s Experience
Patient Outcomes, Preferences, and Attitudes Poster II- 9:00AM-11:00AM
-
Abstract Number: 1217
Evaluation of Post Fracture Management in Males at a Veterans Affairs Health System
Osteoporosis and Metabolic Bone Disease – Clinical Aspects and Pathogenesis Poster II- 9:00AM-11:00AM
-
Abstract Number: 1366
Evaluation of Synovial Fluid 14-3-3η Protein As a Marker of Joint Damage in Rheumatoid Arthritis Patients
Rheumatoid Arthritis – Clinical Aspects Poster II: Pathophysiology, Autoantibodies, and Disease Activity Measures- 9:00AM-11:00AM
-
Abstract Number: 1545
Evaluation of the Adherence to Recommendations for Tnfα Blockers Use and Its Impact over 5 Years of Follow-up in Early Axial Spondyloarthritis. Data from the DESIR Cohort
Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment Poster II- 9:00AM-11:00AM
-
Abstract Number: 1441
Evaluation of Ultrasound-Detecting Efficacy of Abatacept By Profiling Multiple Serum Cytokines, Chemokines and Bone-Related Biomarkers in Rheumatoid Arthritis Patients: Kyushu Multicenter Rheumatoid Arthritis Ultrasound Prospective Observational Cohort Study
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy Poster II: Prognostic Factors, Imaging and Miscellaneous Reports- 9:00AM-11:00AM
-
Abstract Number: 1248
Evaluation of Validated Patient Reported Outcome Measures to Assess Sensitivity to Change in Patients with Systemic Sclerosis and Gastroesophageal Reflux Disease —a Scleroderma Clinical Trials Consortium Collaborative Project
Patient Outcomes, Preferences, and Attitudes Poster II- 9:00AM-11:00AM
-
Abstract Number: 1056
Evolution of Health Care Consumption in the Knee and Hip Osteoarthritis Long Term Assessment Cohort, a French Population Based Cohort of Symptomatic Knee and/or Hip OA Patients
Health Services Research Poster II: Osteoarthritis and Rheumatoid Arthritis- 9:00AM-11:00AM
-
Abstract Number: 1568
Existence of IL-6 and IL-17 Mediated Inflammation Amplifier Loop in Reactive Arthritis
Spondyloarthropathies and Psoriatic Arthritis – Pathogenesis, Etiology Poster II- 9:00AM-11:00AM
-
Abstract Number: 1197
Exploring Determinants Predicting Response to Intra-Articular Hyaluronic Acid Treatment in Symptomatic Knee Osteoarthritis